| Systemic Mastocytosis studied in …STUDIED_INderived62 of 62show fewer |
|---|
| → studied in | NCT03779854Phase 2 · active not recruiting Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant · condition mapped ONTOLOGY_EXACT · 62 trials mapped (17 active) | — | — | Mast Cell Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04910685Phase 2/Phase 3 · recruiting (HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic Mastocytosis · condition mapped ONTOLOGY_EXACT · 62 trials mapped (17 active) | — | — | Indolent Systemic Mastocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04996875Phase 2 · recruiting (Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis · condition mapped ALIAS · 62 trials mapped (17 active) | — | — | Systemic Mastocytosis with an Associated Myeloid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07819396Phase 2 · not yet recruiting Depletion of CD45RA Positive Naive T Cells for the Prevention of Graft Versus Host Disease in Older Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Acute Leukemia or Myelodysplastic Syndrome · condition mapped ONTOLOGY_EXACT · 62 trials mapped (17 active) | — | — | Mast Cell Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07264959recruiting An Observational Study in Participants With Indolent Systemic Mastocytosis (ISM) · condition mapped ONTOLOGY_EXACT · 62 trials mapped (17 active) | — | — | Indolent Systemic Mastocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06210698recruiting Angioedema Biomarker Research Study · condition mapped ONTOLOGY_EXACT · 62 trials mapped (17 active) | — | — | Indolent Systemic Mastocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07757893not yet recruiting Precision Medicine for Indolent Systemic Mastocytosis (PRISM) · condition mapped ONTOLOGY_EXACT · 62 trials mapped (17 active) | — | — | Systemic Mastocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05362773Phase 1 · active not recruiting A Study of MGD024 in Patients With Relapsed or Refractory Hematologic Malignancies · condition mapped ONTOLOGY_EXACT · 62 trials mapped (17 active) | — | — | Aggressive Systemic Mastocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00449748Phase 2 · completed Everolimus (RAD001) as Therapy for Patients With Systemic Mastocytosis · condition mapped ONTOLOGY_EXACT · 62 trials mapped (17 active) | — | — | Systemic Mastocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05186753Phase 2 · active not recruiting (Summit) A Study to Evaluate the Efficacy and Safety of CGT9486 Versus Placebo in Patients With Indolent or Smoldering Systemic Mastocytosis · condition mapped ONTOLOGY_EXACT · 62 trials mapped (17 active) | — | — | Systemic Mastocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07562542recruiting Peripheral Blood KIT-D816V Mutation in Adult Systemic Mastocytosis · condition mapped ONTOLOGY_EXACT · 62 trials mapped (17 active) | — | — | Systemic Mastocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03580655Phase 2 · completed (PATHFINDER) Study to Evaluate Efficacy and Safety of Avapritinib (BLU-285), A Selective KIT Mutation-targeted Tyrosine Kinase Inhibitor, in Patients With Advanced Systemic Mastocytosis · condition mapped ONTOLOGY_EXACT · 62 trials mapped (17 active) | — | — | Aggressive Systemic Mastocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07255638recruiting A Non-Interventional Study in Participants With Indolent Systemic Mastocytosis (ISM) in Germany · condition mapped ONTOLOGY_EXACT · 62 trials mapped (17 active) | — | — | Indolent Systemic Mastocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06327685Phase 1 · recruiting Avapritinib With Decitabine in Patients With SM-AHN · condition mapped ALIAS · 62 trials mapped (17 active) | — | — | Systemic Mastocytosis with an Associated Myeloid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03401060Phase 3 · completed Interest of Denosumab Treatment in Osteoporosis Associated to Systemic Mastocytosis · condition mapped ONTOLOGY_EXACT · 62 trials mapped (17 active) | — | — | Systemic Mastocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06748001Phase 4 · recruiting Avapritinib Rollover Study · condition mapped ONTOLOGY_EXACT · 62 trials mapped (17 active) | — | — | Systemic Mastocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01199562active not recruiting Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant · condition mapped ONTOLOGY_EXACT · 62 trials mapped (17 active) | — | — | Mast Cell Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04681105Phase 1 · completed Flotetuzumab for the Treatment of Relapsed or Refractory Advanced CD123-Positive Hematological Malignancies · condition mapped ONTOLOGY_EXACT · 62 trials mapped (17 active) | — | — | Systemic Mastocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03731260Phase 2 · active not recruiting (PIONEER) Study to Evaluate Efficacy and Safety of Avapritinib (BLU-285), A Selective KIT Mutation-targeted Tyrosine Kinase Inhibitor, Versus Placebo in Patients With Indolent Systemic Mastocytosis · condition mapped ONTOLOGY_EXACT · 62 trials mapped (17 active) | — | — | Indolent Systemic Mastocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07142473recruiting Mastocytosis From Pediatric Age to Adulthood: Local Registry of Cutaneous and Systemic Mastocytosis · condition mapped ONTOLOGY_EXACT · 62 trials mapped (17 active) | — | — | Systemic Mastocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06065007active not recruiting Quality of Life and Disease-related Symptoms in Individuals With Systemic Mastocytosis · condition mapped ONTOLOGY_EXACT · 62 trials mapped (17 active) | — | — | Systemic Mastocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03770273Phase 2 · completed Safety and Efficacy of Subcutaneous Sarilumab in Improving the Quality of Life in People With Indolent Systemic Mastocytosis · condition mapped ONTOLOGY_EXACT · 62 trials mapped (17 active) | — | — | Indolent Systemic Mastocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05219266no longer available Managed Access Programs for PKC412, Midostaurin · condition mapped ONTOLOGY_EXACT · 62 trials mapped (17 active) | — | — | Aggressive Systemic Mastocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04655118Phase 2 · unknown Study of TL-895 in Subjects With Myelofibrosis or Indolent Systemic Mastocytosis · condition mapped ONTOLOGY_EXACT · 62 trials mapped (17 active) | — | — | Indolent Systemic Mastocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05504408unknown Observational Study for the Evaluation of Incidence of Systemic Mastocytosis in t(8;21) Acute Myeloid Leukemia · condition mapped ALIAS · 62 trials mapped (17 active) | — | — | Systemic Mastocytosis with an Associated Myeloid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06013683unknown A Registry for Patients With Systemic Mastocytosis in China · condition mapped ONTOLOGY_EXACT · 62 trials mapped (17 active) | — | — | Systemic Mastocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05923372unknown Evaluation of the DALY on a Cohort of Patients With Indolent Systemic Mastocytosis · condition mapped ONTOLOGY_EXACT · 62 trials mapped (17 active) | — | — | Indolent Systemic Mastocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04333108Phase 3 · unknown Masitinib in Severe Indolent or Smoldering Systemic Mastocytosis Unresponsive to Optimal Symptomatic Treatment · condition mapped ONTOLOGY_EXACT · 62 trials mapped (17 active) | — | — | Indolent Systemic Mastocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02561988Phase 1 · completed (EXPLORER) Study of BLU-285 in Patients With Advanced Systemic Mastocytosis (AdvSM) and Relapsed or Refractory Myeloid Malignancies · condition mapped ONTOLOGY_EXACT · 62 trials mapped (17 active) | — | — | Aggressive Systemic Mastocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03214666Phase 1/Phase 2 · terminated GTB-3550 Tri-Specific Killer Engager (TriKE®) for High Risk Hematological Malignancies · condition mapped ONTOLOGY_EXACT · 62 trials mapped (17 active) | — | — | Systemic Mastocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04695431completed Retrospective Study Assessing the Effect of Avapritinib Versus Best Available Therapy in Patients With AdvSM · condition mapped ONTOLOGY_EXACT · 62 trials mapped (17 active) | — | — | Aggressive Systemic Mastocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00109707Phase 1/Phase 2 · completed A Study of Oral AMN107 in Adults With Chronic Myelogenous Leukemia (CML) or Other Hematologic Malignancies · condition mapped ONTOLOGY_EXACT · 62 trials mapped (17 active) | — | — | Systemic Mastocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03739606Phase 2 · withdrawn Flotetuzumab in Treating Patients With Recurrent or Refractory CD123 Positive Blood Cancer · condition mapped ONTOLOGY_EXACT · 62 trials mapped (17 active) | — | — | Systemic Mastocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01869777NA · completed Bioelectrical Impedance Measurement for Predicting Treatment Outcome in Patients With Newly Diagnosed Acute Leukemia · condition mapped ONTOLOGY_EXACT · 62 trials mapped (17 active) | — | — | Mast Cell Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01334996completed Use of Tamoxifen in Systemic Mastocytosis · condition mapped ONTOLOGY_EXACT · 62 trials mapped (17 active) | — | — | Systemic Mastocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00006251Phase 1/Phase 2 · completed Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine, Mycophenolate Mofetil, Donor Lymphocyte Infusion in Treating Patients With Hematopoietic Cancer · condition mapped ONTOLOGY_EXACT · 62 trials mapped (17 active) | — | — | Mast Cell Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00014235NA · completed Fludarabine Phosphate and Total-Body Radiation Followed by Donor Peripheral Blood Stem Cell Transplant and Immunosuppression in Treating Patients With Hematologic Malignancies · condition mapped ONTOLOGY_EXACT · 62 trials mapped (17 active) | — | — | Mast Cell Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00814073Phase 3 · completed Masitinib in Severe Indolent or Smoldering Systemic Mastocytosis · condition mapped ONTOLOGY_EXACT · 62 trials mapped (17 active) | — | — | Indolent Systemic Mastocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03632811completed Adaptation of the Questionnaire "Regarding Patient's Quality of Life With Mastocytosis" in the French Language · condition mapped ONTOLOGY_EXACT · 62 trials mapped (17 active) | — | — | Indolent Systemic Mastocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02441166NA · completed Diagnostic Value of Bone Marrow Tryptase in Systemic Mastocytosis · condition mapped ONTOLOGY_EXACT · 62 trials mapped (17 active) | — | — | Systemic Mastocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02808793Phase 1 · completed A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AK002 · condition mapped ONTOLOGY_EXACT · 62 trials mapped (17 active) | — | — | Indolent Systemic Mastocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01807598Phase 2 · completed Brentuximab Vedotin in Treating Patients With Advanced Systemic Mastocytosis or Mast Cell Leukemia · condition mapped ONTOLOGY_EXACT · 62 trials mapped (17 active) | — | — | Systemic Mastocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00233454Phase 2 · completed Phase 2 Midostaurin in Aggressive Systemic Mastocytosis and Mast Cell Leukemia · condition mapped ONTOLOGY_EXACT · 62 trials mapped (17 active) | — | — | Systemic Mastocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02415608Phase 2 · terminated Ibrutinib in Treating Patients With Advanced Systemic Mastocytosis · condition mapped ONTOLOGY_EXACT · 62 trials mapped (17 active) | — | — | Systemic Mastocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01273766Phase 2 · completed Deferasirox in Treating Iron Overload Caused By Blood Transfusions in Patients With Hematologic Malignancies · condition mapped ONTOLOGY_EXACT · 62 trials mapped (17 active) | — | — | Mast Cell Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00898079completed Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer · condition mapped ONTOLOGY_EXACT · 62 trials mapped (17 active) | — | — | Mast Cell Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01053494NA · completed Massage Therapy Given by Caregiver in Treating Quality of Life of Young Patients Undergoing Treatment for Cancer · condition mapped ONTOLOGY_EXACT · 62 trials mapped (17 active) | — | — | Mast Cell Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00186628Phase 2 · completed Phase 2 Trial of Prophylactic Rituximab Therapy for Prevention of CGVHD · condition mapped ONTOLOGY_EXACT · 62 trials mapped (17 active) | — | — | Mast Cell Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00118352Phase 2 · completed Alemtuzumab, Fludarabine Phosphate, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer · condition mapped ONTOLOGY_EXACT · 62 trials mapped (17 active) | — | — | Mast Cell Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00112593NA · completed Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer · condition mapped ONTOLOGY_EXACT · 62 trials mapped (17 active) | — | — | Mast Cell Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00171912Phase 2 · completed Imatinib Mesylate in Patients With Various Types of Malignancies Involving Activated Tyrosine Kinase Enzymes · condition mapped ONTOLOGY_EXACT · 62 trials mapped (17 active) | — | — | Systemic Mastocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02380222completed Patient-Reported Outcome Questionnaire for Systemic Mastocytosis · condition mapped PROBABILISTIC · 62 trials mapped (17 active) | — | — | Systemic Mastocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02478957Phase 2 · completed Treatment of Indolent Systemic Mastocytosis With PA101 · condition mapped ONTOLOGY_EXACT · 62 trials mapped (17 active) | — | — | Systemic Mastocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01297777Phase 4 · completed Imatinib in KIT-negative Systemic Mastocytosis · condition mapped ONTOLOGY_EXACT · 62 trials mapped (17 active) | — | — | Systemic Mastocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01602939Phase 2/Phase 3 · unknown Cladribine Plus Pegylated Interpheron Alfa-2a in Systemic Mastocytosis · condition mapped ONTOLOGY_EXACT · 62 trials mapped (17 active) | — | — | Systemic Mastocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01920204Phase 2 · unknown Midostaurin in Indolent Systemic Mastocytosis · condition mapped ONTOLOGY_EXACT · 62 trials mapped (17 active) | — | — | Indolent Systemic Mastocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00387426Phase 2 · terminated Sunitinib in Treating Patients With Idiopathic Myelofibrosis · condition mapped ONTOLOGY_EXACT · 62 trials mapped (17 active) | — | — | Mast Cell Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01231919Phase 1 · completed MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Leukemia · condition mapped ONTOLOGY_EXACT · 62 trials mapped (17 active) | — | — | Mast Cell Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00890747Phase 1 · completed Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy · condition mapped ONTOLOGY_EXACT · 62 trials mapped (17 active) | — | — | Mast Cell Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00493129Phase 2 · completed Ontak (Denileukin Diftitox) in Patients With Systemic Mastocytosis (SM) · condition mapped ONTOLOGY_EXACT · 62 trials mapped (17 active) | — | — | Systemic Mastocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00918931Phase 2 · terminated Obatoclax for Systemic Mastocytosis · condition mapped ONTOLOGY_EXACT · 62 trials mapped (17 active) | — | — | Systemic Mastocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00979160Phase 2 · unknown Evaluation of Response of Dasatinib to Treat Mastocytosis · condition mapped ONTOLOGY_EXACT · 62 trials mapped (17 active) | — | — | Systemic Mastocytosis | 1 | Observed | clinicaltrials | graph → |